Adult-onset STING-associated vasculopathy
Journal of Human Immunity · 06.07.2026 · 2 (4)
DOI: 10.70962/jhi.20250235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 11.05.2026. Verfasst von Thomas R Riley und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Genetic contributions to systemic autoimmunity are often considered more significant in children than in adults. As such, genetic evaluation may be more frequently pursued in pediatric rheumatology patients. Motivated by the discovery of a STING-associated vasculopathy with onset in infancy (SAVI) mutation in a patient with adult-onset relapsing polychondritis and systemic lupus erythematosus, we hypothesized that STING gain-of-function mutations might underlie a broader spectrum of autoimmune disease in adults. We systematically screened 43,731 exomes from the Penn Medicine Biobank, revealing five additional unrelated adults with SAVI-associated STING gain-of-function mutations, including several patients with clinical features of SAVI, as well as asymptomatic individuals with type I IFN signatures. We propose the term adult-onset STING-associated vasculopathy (AO-SAVI) to describe these patients. Our findings challenge the conventional symptom-driven diagnostic paradigm, revealing that parallel molecular classification can uncover shared mechanisms and genetic etiologies across seemingly distinct diseases.
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- RVCL Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Colton Center for Autoimmunity, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
ORCID-Profile: Thomas R Riley, Jonathan J Kotzin, Debby J Park, Shubhasree Banerjee, Asako Takanohashi, Adeline Vanderver, Joshua F Baker, Amanda V Finck, Jonathan J Miner
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- National Institutes of Health
- Penn Colton Center for Autoimmunity
- Veterans Affairs
- H. Ralph Schumacher Rheumatology Research Fund
Zitieren
APA
Riley, T. R., Kotzin, J. J., Park, D. J., Banerjee, S., Takanohashi, A., Vanderver, A., Penn Medicine Biobank, Baker, J. F., Finck, A. V., & Miner, J. J. (2026). Adult-onset STING-associated vasculopathy. Journal of Human Immunity, 2(4). https://doi.org/10.70962/jhi.20250235
Vancouver
Riley TR, Kotzin JJ, Park DJ, Banerjee S, Takanohashi A, Vanderver A, et al. Adult-onset STING-associated vasculopathy. Journal of Human Immunity. 2026;2(4). doi:10.70962/jhi.20250235
BibTeX
@article{Riley2026,
author = {Riley, Thomas R and Kotzin, Jonathan J and Park, Debby J and Banerjee, Shubhasree and Takanohashi, Asako and Vanderver, Adeline and Penn Medicine Biobank, Penn Medicine Biobank and Baker, Joshua F and Finck, Amanda V and Miner, Jonathan J},
title = {Adult-onset STING-associated vasculopathy},
journal = {Journal of Human Immunity},
year = {2026},
volume = {2},
number = {4},
doi = {10.70962/jhi.20250235}
}
EUVIMED